DrugDashboards

Lenalidomide

lenalidomide · LENALIDOMIDE 10 mg/1 · Capsule · Oral · Amneal Pharmaceuticals NY LLC

NDC 60219-1716-02 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00480-1243-28) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$420.40per unit
middle half $242.82–$504.68 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $420.40
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 5 · prior auth 98% · step therapy 0% · qty limit 93%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $13,333.14 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Lenalidomide Shared System REMS

Regulatory

Application
ANDA216213
TE code
AB
Approval date
Jan 31, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of lenalidomide (Capsule)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 10 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.LENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.LENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.LENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.LENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.LENALIDOMIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.LENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Alvogen, Inc.LENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCLENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.LENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.,LENALIDOMIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LENALIDOMIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LENALIDOMIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LENALIDOMIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LENALIDOMIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lenalidomide — NDC 60219-1716-02," retrieved September 3, 2026, https://drugdashboards.com/drug/60219171602.

Free to cite with attribution — see how the data is put together.